20Shots, the B2B game software supplier behind the free-to-play fantasy football game Fantasy5, has secured another £400,000 (€473,081/$482,334) in funding, valuing the business at £5 million.
The supplier has attracted investor interest, including US venture capital fund Animal Capital.
20Shots has not disclosed the amount of Animal Capital’s investment, but the supplier said the funds will be used to support the rollout of its largest range of products to date.
Fantasy5’s Premier League offering is complemented by games covering the UEFA Champions League, Europa League and other top European leagues.
Additional league prizes remain at £10,000, which is offered to players in Premier League games.
Last season, 20Shots also secured the support of BoyleSports, with the bookmaker signing as Fantasy5’s first licensed operator partner.
“As demand increases in the highly competitive free-to-play space, we are rapidly and seamlessly delivering products and games on a white-label basis for many different partners across multiple divisions and competitions. We are investing in our ability to deploy,” said Jacob Kalms, co-founder and CEO of 20Shots.
“Our growth model predicts over 500,000 players this season. By increasing our scale, we are reducing our partner acquisition costs while achieving engagement rates well above the industry average. , stay rates, and retention rates.”
Marshall Sandmann, Managing Partner at Animal Capital, added: It stands out clearly and quickly.
“Their flagship game, Fantasy5, was an early hit, their B2B relationship is uniquely positioned to make this an exciting asset, and their ability to resonate and stick with younger audiences is all part of what makes us That’s why I was so excited to go on the trip.”
